UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.063

Sortiert nach

10 OP Helicobacter pylori VacA cytotoxin stimulates the release of VEGF from human gastric epithelial cells in vitro through an EGF-receptor-mediated pathway

Digestive and liver disease, 2002-06, Vol.34, p.A13-A13

2002

Link zum Volltext

Verfügbarkeit prüfen

102P A retrospective description of actionable mutations incidence within a comprehensive cancer genome profiling programme: Is less still more?

ESMO open, 2024-02, Vol.9, p.102328, Article 102328

2024

Link zum Volltext

Verfügbarkeit prüfen

1042 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY

Journal of hepatology, 2012-04, Vol.56, p.S407-S408

2012

Link zum Volltext

Verfügbarkeit prüfen

1183PDRISK STRATIFICATION MODEL FOR RESECTED SQUAMOUS CELL LUNG CANCER (R-SQLC) PATIENTS (PTS) ACCORDING TO CLINICAL AND PATHOLOGICAL FACTORS

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv412-iv413

2014

Link zum Volltext

Verfügbarkeit prüfen

1197P Somatostatin analogs or active surveillance in sporadic non-functioning pancreatic neuroendocrine tumors

Annals of oncology, 2023-10, Vol.34, p.S706-S707

2023

Link zum Volltext

Verfügbarkeit prüfen

124P Clinicopathological nomogram for predicting fibroblast growth factor receptor 2 (FGFR2) gene fusion/rearrangement (F/R) in intrahepatic cholangiocarcinoma (iCCA)

Annals of oncology, 2023-10, Vol.34, p.S229-S229

2023

Link zum Volltext

Verfügbarkeit prüfen

1289TiP LANTERN study: A multi-omics digital human avatar for integrating precision medicine into clinical practice for lung cancer patients

Annals of oncology, 2023-10, Vol.34, p.S743-S744

2023

Link zum Volltext

Verfügbarkeit prüfen

1309 POSTER How Much is the Likelihood of Being Helped or Harmed (LHH) When Adopting Oral Targeted Agents (OTA) in the Treatment of Advanced Solid Tumours (AST) – Comprehensive Assessment of Their Clinical Overall Impact According to FDA/EMEa Regulatory Approvals

European journal of cancer (1990), 2011, Vol.47, p.S166-S166

2011

Link zum Volltext

Verfügbarkeit prüfen

1363P Genomic heterogeneity of ALK rearrangements and acquired resistance pathways in ALK+ Advanced non-small cell lung cancer (NSCLC) treated with upfront alectinib: Preliminary results of GALILEO project

Annals of oncology, 2023-10, Vol.34, p.S783-S783

2023

Link zum Volltext

Verfügbarkeit prüfen

136P Fertility and sexuality in early onset-colorectal cancer (EO-CRC) patients (pts): A monocentric survey

Annals of oncology, 2024-06, Vol.35, p.S62-S62

2024

Link zum Volltext

Verfügbarkeit prüfen

138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study

ESMO open, 2023-05, Vol.8 (1), p.101477, Article 101477

2023

Link zum Volltext

Verfügbarkeit prüfen

13C-Urea breath test for the diagnosis of Helicobacter pylori infection

European review for medical and pharmacological sciences, 2013, Vol.17 Suppl 2, p.51

2013

Link zum Volltext

Verfügbarkeit prüfen

145P Identification of next generation sequencing (NGS)-based genomic signature predicting resistance to immunotherapy (IO) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): A single-center cohort study

ESMO open, 2023-10, Vol.8 (1), p.101995, Article 101995

2023

Link zum Volltext

Verfügbarkeit prüfen

1510TiP Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant non-small cell lung cancer (NSCLC) according to TP53 mutational status (TEMPLE-2/NCT05785208)

Annals of oncology, 2023-10, Vol.34, p.S850-S850

2023

Link zum Volltext

Verfügbarkeit prüfen

1538P Prognostic impact of leptin (LEP)-mediated meta-inflammation (MI) in patients (pts) receiving maintenance immunotherapy (IT) for extensive-stage small cell lung cancer (ES-SCLC)

Annals of oncology, 2022-09, Vol.33, p.S1250

2022

Link zum Volltext

Verfügbarkeit prüfen

1679P Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis

Annals of oncology, 2023-10, Vol.34, p.S920-S920

2023

Link zum Volltext

Verfügbarkeit prüfen

1884MO Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study

Annals of oncology, 2023-10, Vol.34, p.S1013-S1013

2023

Link zum Volltext

Verfügbarkeit prüfen

18P Clinical outcomes in pT4N0 colon cancer (CC) patients: Data from a large, multicenter, real-word cohort

Annals of oncology, 2024-06, Vol.35, p.S9-S9

2024

Link zum Volltext

Verfügbarkeit prüfen

1901P Immunomodulatory role of multi-agent therapy in thymic epithelial tumours and severe immunological dysregulation

Annals of oncology, 2020-09, Vol.31, p.S1079-S1079

2020

Link zum Volltext

Verfügbarkeit prüfen

191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis

Annals of oncology, 2022-05, Vol.33, p.S215-S215

2022

Link zum Volltext

Verfügbarkeit prüfen

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

2-weekly docetaxel: issues for clinical practice

Cancer biology & therapy, 2015-01, Vol.16 (1), p.17-18

2015

Link zum Volltext

Verfügbarkeit prüfen

2062P The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis

Annals of oncology, 2023-10, Vol.34, p.S1088-S1089

2023

Link zum Volltext

Verfügbarkeit prüfen

2316P Integrating comprehensive cancer genome profiling into clinical practice in an Italian referral center: Results of the first year of the fpg500 programme

Annals of oncology, 2023-10, Vol.34, p.S1183-S1184

2023

Link zum Volltext

Verfügbarkeit prüfen

234 Glucose abnormalities in children with cystic fibrosis (CF)

Journal of cystic fibrosis, 2012-06, Vol.11, p.S116-S116

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.063

Suche als RSS-Feed

Aktive Filter

Publikationsformmagazinearticle

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(944)
Mit Volltextzugriff
(980)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

10 OP Helicobacter pylori VacA cytotoxin stimulates the release of VEGF from human gastric epithelial cells in vitro through an EGF-receptor-mediated pathway

102P A retrospective description of actionable mutations incidence within a comprehensive cancer genome profiling programme: Is less still more?

1042 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY

1183PDRISK STRATIFICATION MODEL FOR RESECTED SQUAMOUS CELL LUNG CANCER (R-SQLC) PATIENTS (PTS) ACCORDING TO CLINICAL AND PATHOLOGICAL FACTORS

1197P Somatostatin analogs or active surveillance in sporadic non-functioning pancreatic neuroendocrine tumors

124P Clinicopathological nomogram for predicting fibroblast growth factor receptor 2 (FGFR2) gene fusion/rearrangement (F/R) in intrahepatic cholangiocarcinoma (iCCA)

1289TiP LANTERN study: A multi-omics digital human avatar for integrating precision medicine into clinical practice for lung cancer patients

1309 POSTER How Much is the Likelihood of Being Helped or Harmed (LHH) When Adopting Oral Targeted Agents (OTA) in the Treatment of Advanced Solid Tumours (AST) – Comprehensive Assessment of Their Clinical Overall Impact According to FDA/EMEa Regulatory Approvals

1363P Genomic heterogeneity of ALK rearrangements and acquired resistance pathways in ALK+ Advanced non-small cell lung cancer (NSCLC) treated with upfront alectinib: Preliminary results of GALILEO project

136P Fertility and sexuality in early onset-colorectal cancer (EO-CRC) patients (pts): A monocentric survey

138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study

13C-Urea breath test for the diagnosis of Helicobacter pylori infection

145P Identification of next generation sequencing (NGS)-based genomic signature predicting resistance to immunotherapy (IO) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): A single-center cohort study

1510TiP Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant non-small cell lung cancer (NSCLC) according to TP53 mutational status (TEMPLE-2/NCT05785208)

1538P Prognostic impact of leptin (LEP)-mediated meta-inflammation (MI) in patients (pts) receiving maintenance immunotherapy (IT) for extensive-stage small cell lung cancer (ES-SCLC)

1679P Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis

1884MO Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study

18P Clinical outcomes in pT4N0 colon cancer (CC) patients: Data from a large, multicenter, real-word cohort

1901P Immunomodulatory role of multi-agent therapy in thymic epithelial tumours and severe immunological dysregulation

191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

2-weekly docetaxel: issues for clinical practice

2062P The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis

2316P Integrating comprehensive cancer genome profiling into clinical practice in an Italian referral center: Results of the first year of the fpg500 programme

234 Glucose abnormalities in children with cystic fibrosis (CF)

Aktive Filter

Suchergebnisse filtern